Document is current
Any future updates will be listed below
-
Authors
Lagnado, Anthony
Leslie, Jack
Ruchaud‐Sparagano, Marie‐Helene
Victorelli, Stella
Hirsova, Petra
Ogrodnik, Mikolaj
Collins, Amy L
Vizioli, Maria Grazia
Habiballa, Leena
Saretzki, Gabriele
Evans, Shane A
Salmonowicz, Hanna
Hruby, Adam
Geh, Daniel
Pavelko, Kevin D
Dolan, David
Reeves, Helen L
Grellscheid, Sushma
Wilson, Colin H
Pandanaboyana, Sanjay
Doolittle, Madison
von Zglinicki, Thomas
Oakley, Fiona
Gallage, Suchira
Wilson, Caroline L
Birch, Jodie https://orcid.org/0000-0003-1727-1125
Carroll, Bernadette
Chapman, James
Heikenwalder, Mathias
Neretti, Nicola
Khosla, Sundeep
Masuda, Claudio Akio
Tchkonia, Tamar https://orcid.org/0000-0003-4623-7145
Kirkland, James L
Jurk, Diana
Mann, Derek A https://orcid.org/0000-0003-0950-243X
Passos, João F https://orcid.org/0000-0001-8765-1890
-
Funding
Funding for this research was provided by:
UKRI | Biotechnology and Biological Sciences Research Council (BB/K017314/1)
UKRI | Biotechnology and Biological Sciences Research Council (BB/L502066/1)
HHS | National Institutes of Health (P01 AG062413)
HHS | National Institutes of Health (R01 AG050582)
Cancer Research UK (C18342/A23390)
UKRI | Medical Research Council (MR/K0019494/1)
UKRI | Medical Research Council (MR/R023026/1)
HHS | NIH | National Institute on Aging (R01 AG 68048)
HHS | NIH | National Institute on Aging (R01 AG068182‐01)
HHS | NIH | National Institute on Aging (R37 AG013925)
HHS | NIH | National Center for Advancing Translational Sciences (UL1 TR0002377)
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
American Association for the Study of Liver Diseases
- License Information
-
More Information
Article History
Received: 24 June 2020
Revised: 9 February 2021
Accepted: 15 February 2021
First Online: 25 March 2021
Conflict of interest
: FO and DAM are directors and shareholders in Fibrofind limited. JL is a shareholder in Fibrofind limited. Patents on INK‐ATTAC mice are held by Mayo Clinic and licensed to Unity Biotechnology. JLK and TT may gain financially from these patents and licenses. This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and was conducted in compliance with Mayo Clinic Conflict of Interest policies. The remaining authors declare no competing financial interests.
